LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Search

DexCom Inc

Abierto

Sector Salud

70.73 1.8

Resumen

Variación precio

24h

Actual

Mínimo

69.48

Máximo

71.44

Métricas clave

By Trading Economics

Ingresos

-2.9M

144M

Ventas

79M

1B

P/B

Media del Sector

73.62

103.001

BPA

0.43

Margen de beneficio

14.35

Empleados

9,600

EBITDA

55M

245M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+48.58 upside

Dividendos

By Dow Jones

Próximas Ganancias

24 oct 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

27B

Apertura anterior

68.93

Cierre anterior

70.73

Noticias sobre sentimiento de mercado

By Acuity

84%

16%

330 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

DexCom Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

26 jul 2024, 20:16 UTC

Ganancias

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 jul 2024, 09:13 UTC

Principales Noticias
Acciones populares

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 jul 2024, 08:56 UTC

Principales Noticias

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 jun 2024, 16:01 UTC

Ganancias

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

17 nov 2023, 12:00 UTC

Principales Noticias

Obesity Drugs Put These Stocks on a Crash Diet, and Now They're Rebounding -- Heard on the Street -- WSJ

27 oct 2023, 08:27 UTC

Ganancias

These Stocks Are Moving the Most Today: Amazon, Intel, Ford, Enphase, Dexcom, Deckers, Exxon, Chevron, and More -- Barrons.com

Comparación entre iguales

Cambio de precio

DexCom Inc Esperado

Precio Objetivo

By TipRanks

48.58% repunte

Estimación a 12 meses

Media 103.28 USD  48.58%

Máximo 160 USD

Mínimo 75 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DexCom Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

18 ratings

14

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

68.61 / 69.82Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

330 / 365 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de DexCom Inc

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.